Análisis de la acción American Well Corporation (AMWL)AMWLAmerican Well Corporation

American Well Corporation operates a hybrid care, delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver access to more affordable quality care. It offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. The Amwell Converge platform offers data architecture and video capabilities, flexibility and scalability, as well as a user experience focused on the needs of patients, members and providers. For health systems, its enterprise platform enables provider-to-provider virtual care for use cases ranging from stroke to virtual nursing and e-sitting. Its Amwell Carepoint devices enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings, helping to address personnel shortages and access limitations. It operates in the Healthcare sector (SERVICES-BUSINESS SERVICES, NEC industry).

American Well Corp is currently a hold. The stock is priced at $12.52, which is below the average analyst price target of $12, indicating limited upside potential in the near term. The RSI is at 37.8, suggesting the stock is nearing oversold territory, but the recent 5-day change of -7.53% indicates downward momentum. The company has shown improvement with a narrowed net loss of $9.6 million in Q2 2026, but risks remain due to ongoing losses and competitive pressures in the telehealth market.